Product correctly added to cart.

Odapipam

CAS 131796-63-9: Odapipam

Description:Odapipam, with the CAS number 131796-63-9, is a chemical compound that functions primarily as a selective antagonist of the dopamine D4 receptor. It is part of a class of compounds that have been investigated for their potential therapeutic applications in various neuropsychiatric disorders, including schizophrenia and attention-deficit hyperactivity disorder (ADHD). Odapipam exhibits a high affinity for the D4 receptor, which is implicated in the modulation of mood, cognition, and behavior. The compound's structure includes a piperazine moiety, which is common in many pharmacologically active substances. Its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are crucial for determining its efficacy and safety profile in clinical settings. Research into Odapipam has focused on its ability to influence dopaminergic pathways, potentially leading to improved outcomes in conditions characterized by dopaminergic dysregulation. As with any pharmacological agent, understanding its mechanism of action and side effects is essential for its therapeutic application.

Formula:C19H20ClNO2

InChI:InChI=1/C19H20ClNO2/c1-21-7-5-13-9-17(20)18(22)10-15(13)16(11-21)14-4-2-3-12-6-8-23-19(12)14/h2-4,9-10,16,22H,5-8,11H2,1H3/t16-/m1/s1

  • Synonyms:
  • Odapipam [INN]
  • (+)-(S)-8-Chloro-5-(2,3-dihydro-7-benzofuranyl)-2,3,4,5-tetrahydro-3-methyl-1H-3-benzazepin-7-ol
  • Nnc 01-0756
  • Nnc 756
  • Unii-847Pqf7Zn6
  • (5S)-8-chloro-5-(2,3-dihydro-1-benzofuran-7-yl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-ol
Sort by


See more categories

This search does not contain any category.

Found 2 products.

discount label

Odapipam

CAS:131796-63-9

Ref: 3D-GFA79663

5mg874.00 €
10mg1,316.00 €
25mg2,145.00 €
50mg3,431.00 €
Estimated delivery in United States, on Wednesday 7 May 2025
discount label

Odapipam

CAS:131796-63-9

Ref: TM-T12288

25mg1,159.00 €
50mg1,510.00 €
100mg2,308.00 €
Estimated delivery in United States, on Wednesday 14 May 2025
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".